SIGA TECHNOLOGIES INC - 8-K Filing
SIGA Technologies reported Q1 2026 revenue of $6.2 million, down from $7.0 million in Q1 2025, with a net loss of $3.5 million, or $0.05 per share, compared to a $0.4 million loss, or $0.01 per share, in the prior year. The company plans to deliver $13 million of oral TPOXX to an Asia Pacific customer in Q2 2026 and $26 million of IV TPOXX to the U.S. government by the end of Q3 2026. SIGA also announced an exclusive license agreement with Hikma for oral TPOXX in the MENA region and paid a $0.60 per share special dividend in April 2026. (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)
Tickers: $SIGA